Trial Profile
A randomized, open label, assessor-blind, parallel group, multi centre Phase III study to compare the efficacy and safety of r-hMG and HP-hMG in subjects undergoing controlled ovarian stimulation for ART
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Menotropins (Primary)
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Sponsors Bharat Serums and Vaccines
- 26 Mar 2019 Status has been changed to recruiting.
- 11 Sep 2018 Status changed from recruiting to completed.
- 26 Mar 2018 Status changed from not yet recruiting to recruiting.